Data from Qualigen Therapeutics’ Lead Program QN-302 Accepted as Three Poster Presentations at AACR 2022 Conference
Posters to be Presented During the In-Person Conference Being Held April 8-13, 2022 in New…
News
Statera Biopharma, Inc., Announces Central Institutional Review Board Approval of Phase 3 Clinical Trial for Pediatric Crohn’s Disease
STAT-201 is being developed as a novel, immune-modulation therapy for treating Crohn’s Disease Phase 3 trial…
AXIM Biotech Announces New Milestones in Preparation of Dry Eye Disease Diagnostics Launch
AXIM is driven to positively transform the state of Dry Eye Disease (DED) testing and…
Digipath Announces Financial Results for Q1, 2022
Quarter Saw Large Increases Quarter Over Same Quarter Gross Profit and Revenue Gains LAS VEGAS,…
Athenex Announces Completion of Sale of Dunkirk Manufacturing Facility
BUFFALO, N.Y., Feb. 15, 2022 (GLOBE NEWSWIRE) — Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical…
Renibus Therapeutics Announces Appointment of Frank Stonebanks as CEO and $35 Million Series A Funding
Frank Stonebanks Headshot Frank Stonebanks, CEO, Renibus Therapeutics Founder, CEO and healthcare venture capitalist, Stonebanks…
Novan to Report Full Year 2021 Financial Results on February 22, 2022
DURHAM, N.C., Feb. 15, 2022 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (Nasdaq:…
Sunshine Biopharma, Inc. Announces Pricing of $8 Million Public Offering and Uplisting to the Nasdaq Capital Market
MONTREAL, Feb. 15, 2022 (GLOBE NEWSWIRE) — Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the…
Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2021 Financial Report
Conference Call on Tuesday, March 1, 2022 at 8:30 a.m. ET LEXINGTON, Mass., Feb. 15,…
Healthy Extracts New Clinical Study Demonstrates UBN RELIEF Naturally Alleviates Migraine Symptoms
Double-Blind, Peer-Reviewed Study Published in World Journal of Advanced Research and Reviews UBN RELIEF™ UBN…
Palisade Bio (NASDAQ: PALI) Adds Pharmaceutical Industry Executive Robert McRae to Leadership Team
Expands Clinical Operations Team in Advance of Pivotal Clinical Studies CARLSBAD, Calif., Feb. 15, 2022…
Monopar Announces Clinical and Preclinical Program Updates
Validive Phase 2b/3 VOICE trial now open at 43 sites; active and enrolling in US…
Propella Therapeutics Presents Non-Clinical Data on PRL-02 at 2022 ASCO Genitourinary (GU) Cancers Symposium
Highlights Potential of PRL-02 as Best-in-Class, Next-Generation Androgen Biosynthesis Inhibitor for Treatment of Advanced Prostate…
Zogenix Supports New No-Cost Genetic Testing Program with United Mitochondrial Disease Foundation to Improve Diagnosis of Mitochondrial Diseases
Symptoms of mitochondrial diseases, such as Thymidine Kinase 2 deficiency (TK2d), can vary widely and…
PDS Biotech Announces Clinical Trial with Mayo Clinic to Study PDS0101 in Early Stage Pre-Metastatic- HPV-Associated Head and Neck Cancer
The study evaluates PDS0101 with and without KEYTRUDA® prior to surgery for HPV-associated oropharyngeal cancer…
Hepion Pharmaceuticals Appoints World-Renowned Hepatologist, Dr. Eddie C. Cheung, to Lead the Company’s Strategic Medical Affairs in Asia
– Dr. Cheung, who has dedicated his career to NASH, hepatocellular carcinoma, fatty liver disease,…
Stella Diagnostics CEO Discusses Competitive Advantage in Early Cancer Detection During Audio Interview with SmallCapVoice.com
SmallCapVoice.com Interview with Stella Diagnostics Inc. SmallCapVoice.com Inc. (“SCV”) announces the availability of a new…
Portage Biotech Announces New Appointments to its Management Team and Board of Directors
Leading biopharma executive Brian Wiley joins as Chief Business Officer Experienced financial consultant Joseph Ciaverella…
Amarin to Report Fourth Quarter and Full Year 2021 Financial Results And Host Conference Call on March 1, 2022
DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 15, 2022 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN)…
Cue Biopharma’s Therapeutic Immuno-STAT Biologics to be Featured in Oxford University Presentation at the Biophysical Society 2022 Annual Meeting
Presentation provides mechanistic insights and progress update on collaboration with the laboratory of Michael Dustin…